arrow
J

Jan H. Beumer

 johns hopkins university
H指数:47
被引数:7,161

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Fibroblast growth factor receptor inhibition for succinate dehydrogenase-deficient gastrointestinal stromal tumors: a phase 2 trial

针对琥珀酸脱氢酶缺陷型胃肠道间质瘤的成纤维细胞生长因子受体抑制:一项2期临床试验

2026-05-260
OAAI
Phase 2 Study of Cabozantinib (XL184) with Nivolumab and Ipilimumab for the Treatment of Poorly Differentiated Neuroendocrine Carcinomas (ETCTN10315)

卡博替尼(XL184)联合纳武利尤单抗和伊匹木单抗治疗低分化神经内分泌癌的2期研究(ETCTN10315)

2026-04-100
OA
A phase 1 study of orally administered 5-fluoro-2’-deoxycytidine with tetrahydrouridine in patients with refractory solid tumors

一项关于口服给予5-氟-2’-脱氧胞苷与四氢尿嘧啶联合治疗难治性实体瘤的1期研究

2025-12-220
OAAI
Association of SULT2A1 Locus With Abiraterone Clearance in the Alliance A031201: Randomized Phase III Study of Enzalutamide Compared With Enzalutamide Plus Abiraterone for Metastatic Castration-Resistant Prostate Cancer

SULT2A1基因位点与Abiraterone清除率的关联性:Alliance A031201研究——一项比较Enzalutamide与Enzalutamide联合Abiraterone治疗转移性去势抵抗性前列腺癌的随机III期研究

2025-12-050
OAAI
Letrozole, abemaciclib and metformin in endometrial cancer: a non-randomized phase 2 trial

来曲唑、阿贝西利和二甲双胍在子宫内膜癌中的应用:一项非随机性Ⅱ期临床试验

2025-12-030
OAAI
Phase Ib study of enzalutamide with venetoclax in patients with metastatic castration-resistant prostate cancer

Ib期研究:恩扎卢胺联合维奈克拉用于转移性去势抵抗性前列腺癌患者的治疗

2025-11-290
OAAI
The ATR Inhibitor Elimusertib in Combination with Cisplatin in Patients with Advanced Solid Tumors: A California Cancer Consortium Phase I Trial (NCI 10404)
2025-11-010
OA
Phase Ib study of berzosertib, carboplatin, gemcitabine, and pembrolizumab in patients with squamous nonsmall lung cancer (ETCTN 10313)

伯佐塞替、卡铂、吉西他滨和帕博利珠单抗在鳞状非小细胞肺癌患者中的 Ib 期研究 (ETCTN 10313)

2025-11-010
OAAI
Clinical and translational study of ivosidenib plus nivolumab in advanced solid tumors harboring IDH1 mutations

Nguyen, M.K.; Jelinek, M.; Singh, A.; Isett, B.; Myers, E.S.; Mullett, S.J.; Eisele, Y.; Beumer, J.; Parise, R.; Urban, J.; et al. 关于ivosidenib联合nivolumab治疗携带IDH1突变的晚期实体瘤的临床与转化研究。medRxiv 2025. [Google Scholar] [CrossRef]

2025-11-010
PRE
Phase 1 studies of the indenoisoquinolines LMP776 and LMP744 in patients with solid tumors and lymphomas

I期研究评估吲哚异喹啉类化合物LMP776和LMP744在实体瘤和淋巴瘤患者中的应用

2025-05-290
OAAI
Phase I trial of ATR inhibitor elimusertib with FOLFIRI in advanced or metastatic gastrointestinal malignancies (ETCTN 10406)

I期临床试验:ATR抑制剂elimusertib联合FOLFIRI方案治疗晚期或转移性胃肠道恶性肿瘤(ETCTN 10406)

2025-01-221
PRE
Assessment of Glomerular Filtration Rate in Patients with Cancer: A Statement from the American Society of Onco-Nephrology

评估癌症患者的肾小球滤过率: 美国肿瘤学会的声明

2024-06-071
PRE
Assessment of GFR in Patients with Cancer Part 2: Anticancer Therapies - Perspectives from the ASON

癌症患者GFR的评估第2部分: 抗癌治疗-ASON的观点

2024-06-070
OA